adenine has been researched along with Tumour Lysis Syndrome in 6 studies
Excerpt | Relevance | Reference |
---|---|---|
"Discussion One patient with chronic lymphocytic leukemia/small lymphocytic lymphoma and one patient with mantle cell lymphoma developed laboratory and clinical tumor lysis syndrome following initiation of ibrutinib therapy." | 2.58 | Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature. ( Brown, JN; Hammond, JM; Titus-Rains, KS, 2018) |
"Tumor lysis syndrome is an oncologic emergency resulting from rapid and massive tumor cell death that may lead to serious clinical complications including acute kidney injury and cardiac arrest." | 1.56 | Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib. ( Brener, H; Brener, ZZ; Losev, A, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barr, PM | 2 |
Tedeschi, A | 1 |
Wierda, WG | 2 |
Allan, JN | 1 |
Ghia, P | 2 |
Vallisa, D | 1 |
Jacobs, R | 1 |
O'Brien, S | 2 |
Grigg, AP | 1 |
Walker, P | 1 |
Zhou, C | 2 |
Ninomoto, J | 2 |
Krigsfeld, G | 1 |
Tam, CS | 2 |
Brener, ZZ | 1 |
Brener, H | 1 |
Losev, A | 1 |
Titus-Rains, KS | 1 |
Brown, JN | 1 |
Hammond, JM | 1 |
Byrd, JC | 1 |
Coutre, S | 1 |
Furman, RR | 1 |
Kipps, TJ | 1 |
Burger, JA | 1 |
Stevens, DA | 1 |
Sharman, J | 1 |
Flinn, IW | 1 |
James, DF | 1 |
Kaur, V | 2 |
Mehta, P | 1 |
Johnsurd, J | 1 |
Govindarajan, R | 1 |
Swami, A | 1 |
1 review available for adenine and Tumour Lysis Syndrome
Article | Year |
---|---|
Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature.
Topics: Adenine; Aged; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Piperidi | 2018 |
5 other studies available for adenine and Tumour Lysis Syndrome
Article | Year |
---|---|
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cr | 2022 |
Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib.
Topics: Adenine; Aged; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Protein Ki | 2020 |
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
Topics: Adenine; Aged; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; | 2019 |
Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
Topics: Adenine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Pyrazoles; | 2014 |
Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report.
Topics: Adenine; Aged; Antineoplastic Agents; Humans; Lymphoma, Mantle-Cell; Male; Piperidines; Protein Kina | 2017 |